During CAR T therapy, DAMPs leakage by pyroptotic tumor cells activate macrophages and induce the release of IL-1β and IL-6, triggering CRS, highlighting the involvement of pyroptosis-DAMPs axis in CARTOX. Here, IL6 is linked to congenital rubella syndrome.